Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

Europe - EPA:ERA - FR0000131757 - Common Stock

51.6 EUR
+0.2 (+0.39%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

3

ERA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 38 industry peers in the Metals & Mining industry. ERA may be in some trouble as it scores bad on both profitability and health. ERA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ERA had negative earnings in the past year.
In the past year ERA has reported a negative cash flow from operations.
Of the past 5 years ERA 4 years were profitable.
ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

ERA has a Return On Assets of -1.58%. This is in the lower half of the industry: ERA underperforms 71.05% of its industry peers.
With a Return On Equity value of -9.29%, ERA is not doing good in the industry: 76.32% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 0.84%, ERA is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
ERA had an Average Return On Invested Capital over the past 3 years of 7.61%. This is in line with the industry average of 8.13%.
The 3 year average ROIC (7.61%) for ERA is well above the current ROIC(0.84%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROIC 0.84%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

ERA's Profit Margin has declined in the last couple of years.
The Operating Margin of ERA (1.91%) is worse than 73.68% of its industry peers.
ERA's Operating Margin has declined in the last couple of years.
ERA has a better Gross Margin (68.15%) than 94.74% of its industry peers.
ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.91%
PM (TTM) N/A
GM 68.15%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ERA is destroying value.
The number of shares outstanding for ERA has been increased compared to 1 year ago.
The number of shares outstanding for ERA has been increased compared to 5 years ago.
Compared to 1 year ago, ERA has an improved debt to assets ratio.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ERA has an Altman-Z score of 1.08. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.08, ERA is doing worse than 78.95% of the companies in the same industry.
ERA has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
ERA has a worse Debt to Equity ratio (2.03) than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACC0.09
WACC9.31%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.54 indicates that ERA should not have too much problems paying its short term obligations.
The Current ratio of ERA (1.54) is worse than 71.05% of its industry peers.
ERA has a Quick Ratio of 1.06. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.06, ERA perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.06
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

The earnings per share for ERA have decreased strongly by -221.18% in the last year.
ERA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.00% yearly.
The Revenue has decreased by -6.91% in the past year.
Measured over the past years, ERA shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%

3.2 Future

ERA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.34% yearly.
Based on estimates for the next years, ERA will show a small growth in Revenue. The Revenue will grow by 7.96% on average per year.
EPS Next Y-274.73%
EPS Next 2Y-2.62%
EPS Next 3Y29.34%
EPS Next 5YN/A
Revenue Next Year6.12%
Revenue Next 2Y7.49%
Revenue Next 3Y7.96%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 12.97, ERA is valued correctly.
Based on the Price/Forward Earnings ratio, ERA is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, ERA is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.97
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

71.05% of the companies in the same industry are cheaper than ERA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.54
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

A more expensive valuation may be justified as ERA's earnings are expected to grow with 29.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.62%
EPS Next 3Y29.34%

3

5. Dividend

5.1 Amount

ERA has a Yearly Dividend Yield of 2.92%. Purely for dividend investing, there may be better candidates out there.
ERA's Dividend Yield is a higher than the industry average which is at 2.77.
Compared to an average S&P500 Dividend Yield of 2.38, ERA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of ERA are negative and hence is the payout ratio. ERA will probably not be able to sustain this dividend level.
DP-44.33%
EPS Next 2Y-2.62%
EPS Next 3Y29.34%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

ERAMET

EPA:ERA (9/18/2025, 7:00:00 PM)

51.6

+0.2 (+0.39%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.48B
Analysts52.73
Price Target53.24 (3.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.42%
PT rev (3m)-17.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-513.67%
EPS NY rev (3m)-513.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.97
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 2.75
EV/EBITDA 14.54
EPS(TTM)-3.44
EYN/A
EPS(NY)3.98
Fwd EY7.71%
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROCE 1.16%
ROIC 0.84%
ROICexc 0.99%
ROICexgc 1.13%
OM 1.91%
PM (TTM) N/A
GM 68.15%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexcg growth 3Y-56.22%
ROICexcg growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Debt/EBITDA 10.29
Cap/Depr 403.31%
Cap/Sales 21.11%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.06
Altman-Z 1.08
F-Score2
WACC9.31%
ROIC/WACC0.09
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-274.73%
EPS Next 2Y-2.62%
EPS Next 3Y29.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year6.12%
Revenue Next 2Y7.49%
Revenue Next 3Y7.96%
Revenue Next 5YN/A
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year104.71%
EBIT Next 3Y37.27%
EBIT Next 5YN/A
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A